The global market for medical electronics is projected to reach $8.8 billion by 2026, driven by factors such as an aging population, increasing awareness about healthcare and disease prevention and proliferation of user-friendly electronic systems: smartphones, smart watches, fitness trackers and many others.
We are working on the development of microelectronic devices for bidirectional bioelectronic interfacing in vitro. Such devices are necessary for electrophysiological and chemical functional characterization of the developed human-derived cell models across scales - from subcellular units through individual cells to networks - for drug screening and personalized medicine.
Electrical stimulation has been shown to enable several beneficial therapeutic effects such as biological tissue regeneration, pain management, wound healing and drug delivery. This thrust will focus on development of low-power programmable voltage and current mode stimulation cells to enable delivery of precise dosage of electrical stimulus to the patients for therapeutic applications.